Chengdu Huasun Group Inc Ltd (000790) - Total Liabilities
Based on the latest financial reports, Chengdu Huasun Group Inc Ltd (000790) has total liabilities worth CN¥911.88 Million CNY (≈ $133.44 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 000790 net asset momentum to track the company's year-over-year net asset growth rate.
Chengdu Huasun Group Inc Ltd - Total Liabilities Trend (1995–2024)
This chart illustrates how Chengdu Huasun Group Inc Ltd's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of Chengdu Huasun Group Inc Ltd to measure how efficiently the company converts operating cash flow to free cash.
Chengdu Huasun Group Inc Ltd Competitors by Total Liabilities
The table below lists competitors of Chengdu Huasun Group Inc Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A
SHG:600613
|
China | CN¥640.98 Million |
|
Gigastorage Corp
TW:2406
|
Taiwan | NT$7.15 Billion |
|
Zilltek Technology Corp
TWO:6679
|
Taiwan | NT$735.95 Million |
|
Dufu Tech Corp Bhd
KLSE:7233
|
Malaysia | RM98.73 Million |
|
Compass Therapeutics Inc.
NASDAQ:CMPX
|
USA | $18.70 Million |
|
Digital Network S.A.
WAR:DIG
|
Poland | zł241.63 Million |
|
Yungshin Construction & Development Co Ltd
TWO:5508
|
Taiwan | NT$13.75 Billion |
|
3I Group PLC
LSE:III
|
UK | GBX1.42 Billion |
Liability Composition Analysis (1995–2024)
This chart breaks down Chengdu Huasun Group Inc Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 000790 market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.68 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.98 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.49 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Chengdu Huasun Group Inc Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Chengdu Huasun Group Inc Ltd (1995–2024)
The table below shows the annual total liabilities of Chengdu Huasun Group Inc Ltd from 1995 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥1.18 Billion ≈ $172.86 Million |
+11.75% |
| 2023-12-31 | CN¥1.06 Billion ≈ $154.68 Million |
+57.41% |
| 2022-12-31 | CN¥671.56 Million ≈ $98.27 Million |
+81.66% |
| 2021-12-31 | CN¥369.68 Million ≈ $54.10 Million |
+62.45% |
| 2020-12-31 | CN¥227.56 Million ≈ $33.30 Million |
-11.73% |
| 2019-12-31 | CN¥257.78 Million ≈ $37.72 Million |
+3.71% |
| 2018-12-31 | CN¥248.55 Million ≈ $36.37 Million |
-48.98% |
| 2017-12-31 | CN¥487.19 Million ≈ $71.29 Million |
+14.58% |
| 2016-12-31 | CN¥425.19 Million ≈ $62.22 Million |
+24.14% |
| 2015-12-31 | CN¥342.50 Million ≈ $50.12 Million |
-20.39% |
| 2014-12-31 | CN¥430.24 Million ≈ $62.96 Million |
+0.91% |
| 2013-12-31 | CN¥426.37 Million ≈ $62.39 Million |
+16.51% |
| 2012-12-31 | CN¥365.96 Million ≈ $53.55 Million |
-1.04% |
| 2011-12-31 | CN¥369.79 Million ≈ $54.11 Million |
+19.81% |
| 2010-12-31 | CN¥308.63 Million ≈ $45.16 Million |
-0.17% |
| 2009-12-31 | CN¥309.15 Million ≈ $45.24 Million |
-16.33% |
| 2008-12-31 | CN¥369.49 Million ≈ $54.07 Million |
+27.32% |
| 2007-12-31 | CN¥290.20 Million ≈ $42.47 Million |
+7.12% |
| 2006-12-31 | CN¥270.92 Million ≈ $39.64 Million |
-5.56% |
| 2005-12-31 | CN¥286.87 Million ≈ $41.98 Million |
+16.89% |
| 2004-12-31 | CN¥245.43 Million ≈ $35.91 Million |
+36.20% |
| 2003-12-31 | CN¥180.20 Million ≈ $26.37 Million |
+8.69% |
| 2002-12-31 | CN¥165.79 Million ≈ $24.26 Million |
+12.14% |
| 2001-12-31 | CN¥147.83 Million ≈ $21.63 Million |
-11.70% |
| 2000-12-31 | CN¥167.42 Million ≈ $24.50 Million |
+25.13% |
| 1999-12-31 | CN¥133.80 Million ≈ $19.58 Million |
+45.71% |
| 1998-12-31 | CN¥91.82 Million ≈ $13.44 Million |
+134.84% |
| 1997-12-31 | CN¥39.10 Million ≈ $5.72 Million |
+79.92% |
| 1996-12-31 | CN¥21.73 Million ≈ $3.18 Million |
-13.74% |
| 1995-12-31 | CN¥25.19 Million ≈ $3.69 Million |
-- |
About Chengdu Huasun Group Inc Ltd
Chengdu huasun technology group Inc. , LTD. manufactures and sells medicines, bio-pharmaceutical products, and building steel structures. The company manufactures modern Chinese medicines, Chinese patent medicines, chemical medicines, and drugs. It also engages in the research and development, production, and sale of biological products and biotechnology drugs; and medicines for the treatment of … Read more